Delivery Order SPE2DB22D2206-SPE2DB25FJE85
Award Date 8/1/25
Potential Completion Date 8/22/25
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,468.56 for GAMUNEX-C 1 gram/10 mL vials on August 26, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin used to treat primary immunodeficiency and other...
- The Defense Logistics Agency awarded a $13,963.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on June 30, 2025, with an ultimate completion date of July 22, 2025. GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat various immunodeficiency conditions and autoimmune disorders. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with firm fixed pricing. This is a non-set-aside delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is executing this...
- The Defense Logistics Agency awarded a $17,702.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 18, 2025, with an ultimate completion date of October 9, 2025. GAMUNEX-C is an intravenous immunoglobulin used to treat immunodeficiency disorders and autoimmune conditions. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a $55,852.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on May 9, 2025, with an ultimate completion date of June 2, 2025. GAMUNEX-C is an intravenous immunoglobulin therapy used to treat immunodeficiency conditions and autoimmune disorders. This non-set-aside competitive award represents a single delivery order fulfillment under AmerisourceBergen's broader contract vehicle with the DLA. The work will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,104.70 for GAMUNEX-C 10 gram/100 mL vials on August 19, 2025, with completion expected by September 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) therapeutic used to treat various immune-related conditions, representing...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $55,852.80 delivery order on August 18, 2025, for GAMUNEX-C 40 gram/400 ml vials with a completion date of September 9, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) therapy used to treat immune deficiencies and certain autoimmune and inflammatory...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This is a firm fixed price contract with an ultimate completion date of September 24, 2025, and represents a non-set-aside competitive award. The delivery will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $56.6K delivery order to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 20 gram/200 milliliter vials on September 9, 2025, with a completion deadline of September 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIg) product used to treat various immunodeficiency conditions...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials, with a contract ceiling value of $2,327.20 and an ultimate completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...